Oral Human Papillomavirus in Men Having Sex with Men: Risk-Factors and Sampling

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Read, Tim R H ^a,b   Hocking, Jane S ^b   Vodstrcil, Lenka A ^a,b   Tabrizi, Sepehr N ^b   McCullough, Michael J ^c   Grulich, Andrew E ^d   Garland, Suzanne M ^b   Bradshaw, Catriona S ^a,e   Chen, Marcus Y ^a,b   Fairley, Christopher K ^a,b  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING; EATING; EJACULATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; ORAL ANAL SEX; ORAL HUMAN PAPILLOMAVIRUS; ORAL PENILE SEX; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SMOKING; TONGUE KISSING; TOOTH BRUSHING; VIRUS DETECTION; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MOUTH; RISK FACTORS; SEXUAL BEHAVIOR; VACCINATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84869228805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049324     Document Type: Article

References (28)

1. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720.
2. Hong AM, Grulich AE, Jones D, Lee CS, Garland SM, et al. (2010) Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 28: 3269-3272.
3. Kreimer AR, Clifford GM, Boyle P, Franceschi S, (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475.
4. Hong A, Grulich A, Jones D, Lee S, Garland S, et al. (2010) Oropharyngeal cancer. Australian data show increase. Bmj 340: c2518.
5. Hocking JS, Stein A, Conway EL, Regan D, Grulich A, et al. (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104: 886-891.
6. Sturgis EM, Cinciripini PM, (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110: 1429-1435.
7. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML, (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199: 1263-1269.
8. D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, et al. (2007) Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 121: 143-150.
9. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, et al. (2012) Prevalence of oral HPV infection in the United States, 2009-2010. Jama 307: 693-703.
10. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, et al. (2004) Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189: 686-698.
11. Marais DJ, Passmore JA, Denny L, Sampson C, Allan BR, et al. (2008) Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol 80: 953-959.
12. Steinau M, Reddy D, Sumbry A, Reznik D, Gunthel CJ, et al. (2012) Oral sampling and human papillomavirus genotyping in HIV-infected patients. J Oral Pathol Med.
13. AustraliaPost (2009) Dangerous & Prohibited Goods & Packaging Post Guide.
14. Parisi SG, Cruciani M, Scaggiante R, Boldrin C, Andreis S, et al. (2011) Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis 11: 150.
15. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, et al. (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87: 544-547.
16. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, et al. (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361.
17. Garland SM, Tabrizi SN, Chen S, Byambaa C, Davaajav K, (2001) Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia. Infect Dis Obstet Gynecol 9: 143-146.
18. Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA, et al. (2007) Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 45: 2130-2137.
19. Stevens MP, Garland SM, Tabrizi SN, (2008) Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test. J Clin Microbiol 46: 3813-3816.
20. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125: 2151-2158.
21. Vajdic CM, van Leeuwen MT, Jin F, Prestage G, Medley G, et al. (2009) Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 85: 330-335.
22. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, et al. (2004) Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 189: 677-685.
23. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956.
24. Taybos G, (2003) Oral changes associated with tobacco use. Am J Med Sci 326: 179-182.
25. Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, et al. (2012) Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 21: 122-133.
26. Brown B, Blas MM, Cabral A, Carcamo C, Gravitt PE, et al. (2011) Oral sex practices, oral human papillomavirus and correlations between oral and cervical human papillomavirus prevalence among female sex workers in Lima, Peru. Int J STD AIDS 22: 655-658.
27. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD, (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423-428.
28. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218-226.